D-0076-2021 Class II Terminated

Recalled by Baxter Healthcare Corporation — Deerfield, IL

Recall Details

Product Type
Drugs
Report Date
November 18, 2020
Initiation Date
October 7, 2020
Termination Date
May 22, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx only, Manufactured for: Baxter Healthcare Corporation Deerfield, IL 60015 USA, Manufactured by: Baxter Pharmaceuticals India Private Ltd Ahmedabad 382213 India, NDC 36000-092-10

Reason for Recall

Presence of particulate matter in solution - black and transparent particles

Distribution Pattern

Nationwide USA

Code Information

Lot #: A0B1241, Exp 10/2020; A0C0091, Exp 12/2020; A0D0268, Exp 02/2022